TY - JOUR AU - Dienstmann, R. AU - Rodon, J. AU - Serra, V. AU - Tabernero, J. PY - 2014 DA - 2014// TI - Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors JO - Mol Cancer Ther VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-13-0639 DO - 10.1158/1535-7163.MCT-13-0639 ID - Dienstmann2014 ER - TY - JOUR AU - Lindsley, C. W. AU - Barnett, S. F. AU - Layton, M. E. AU - Bilodeau, M. T. PY - 2008 DA - 2008// TI - The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors JO - Curr Cancer Drug Targets VL - 8 UR - https://doi.org/10.2174/156800908783497096 DO - 10.2174/156800908783497096 ID - Lindsley2008 ER - TY - JOUR AU - Engelman, J. A. PY - 2009 DA - 2009// TI - Targeting PI3K signalling in cancer: opportunities, challenges and limitations JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2664 DO - 10.1038/nrc2664 ID - Engelman2009 ER - TY - JOUR AU - Schwarz, J. K. AU - Payton, J. E. AU - Rashmi, R. AU - Xiang, T. AU - Jia, Y. AU - Huettner, P. PY - 2012 DA - 2012// TI - Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2485 DO - 10.1158/1078-0432.CCR-11-2485 ID - Schwarz2012 ER - TY - JOUR AU - Gonzalez, E. AU - McGraw, T. E. PY - 2009 DA - 2009// TI - The Akt kinases: isoform specificity in metabolism and cancer JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.16.9335 DO - 10.4161/cc.8.16.9335 ID - Gonzalez2009 ER - TY - STD TI - Molife LR, Yan L, Vitfell-Rasmussen J, Zernhelt AM, Sullivan DM, Cassier PA, et al. Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. J Hematol Oncol. 2014;7(1). ID - ref6 ER - TY - JOUR AU - Okuzumi, T. AU - Fiedler, D. AU - Zhang, C. AU - Gray, D. C. AU - Aizenstein, B. AU - Hoffman, R. PY - 2009 DA - 2009// TI - Inhibitor hijacking of Akt activation JO - Nat Chem Biol VL - 5 UR - https://doi.org/10.1038/nchembio.183 DO - 10.1038/nchembio.183 ID - Okuzumi2009 ER - TY - JOUR AU - Hirai, H. AU - Sootome, H. AU - Nakatsuru, Y. AU - Miyama, K. AU - Taguchi, S. AU - Tsujioka, K. PY - 2010 DA - 2010// TI - MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-09-1012 DO - 10.1158/1535-7163.MCT-09-1012 ID - Hirai2010 ER - TY - JOUR AU - Simioni, C. AU - Martelli, A. M. AU - Cani, A. AU - Cetin-Atalay, R. AU - McCubrey, J. A. AU - Capitani, S. PY - 2013 DA - 2013// TI - The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy JO - Oncotarget. VL - 4 UR - https://doi.org/10.18632/oncotarget.1236 DO - 10.18632/oncotarget.1236 ID - Simioni2013 ER - TY - JOUR AU - Meng, J. AU - Dai, B. AU - Fang, B. AU - Bekele, B. N. AU - Bornmann, W. G. AU - Sun, D. PY - 2010 DA - 2010// TI - Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0014124 DO - 10.1371/journal.pone.0014124 ID - Meng2010 ER - TY - JOUR AU - She, Q. -. B. AU - Chandarlapaty, S. AU - Ye, Q. AU - Lobo, J. AU - Haskell, K. M. AU - Leander, K. R. PY - 2008 DA - 2008// TI - Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0003065 DO - 10.1371/journal.pone.0003065 ID - She2008 ER - TY - JOUR AU - Banerji, S. AU - Cibulskis, K. AU - Rangel-Escareno, C. AU - Brown, K. K. AU - Carter, S. L. AU - Frederick, A. M. PY - 2012 DA - 2012// TI - Sequence analysis of mutations and translocations across breast cancer subtypes JO - Nature. VL - 486 UR - https://doi.org/10.1038/nature11154 DO - 10.1038/nature11154 ID - Banerji2012 ER - TY - JOUR AU - Carpten, J. D. AU - Faber, A. L. AU - Horn, C. AU - Donoho, G. P. AU - Briggs, S. L. AU - Robbins, C. M. PY - 2007 DA - 2007// TI - A transforming mutation in the pleckstrin homology domain of AKT1 in cancer JO - Nature. VL - 448 UR - https://doi.org/10.1038/nature05933 DO - 10.1038/nature05933 ID - Carpten2007 ER - TY - JOUR AU - Sangai, T. AU - Akcakanat, A. AU - Chen, H. AU - Tarco, E. AU - Wu, Y. AU - Do, K. -. A. PY - 2012 DA - 2012// TI - Biomarkers of response to Akt inhibitor MK-2206 in breast cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1141 DO - 10.1158/1078-0432.CCR-12-1141 ID - Sangai2012 ER - TY - JOUR AU - Davies, B. R. AU - Greenwood, H. AU - Dudley, P. AU - Crafter, C. AU - Yu, D. -. H. AU - Zhang, J. PY - 2012 DA - 2012// TI - Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0824-T DO - 10.1158/1535-7163.MCT-11-0824-T ID - Davies2012 ER - TY - JOUR AU - Vadlakonda, L. AU - Pasupuleti, M. AU - Pallu, R. PY - 2013 DA - 2013// TI - Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells JO - Front Oncol VL - 3 ID - Vadlakonda2013 ER - TY - JOUR AU - Martelli, A. M. AU - Evangelisti, C. AU - Follo, M. Y. AU - Ramazzotti, G. AU - Fini, M. AU - Giardino, R. PY - 2011 DA - 2011// TI - Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells JO - Curr Med Chem VL - 18 UR - https://doi.org/10.2174/092986711796011201 DO - 10.2174/092986711796011201 ID - Martelli2011 ER - TY - JOUR AU - Fujiwara, K. AU - Iwado, E. AU - Mills, G. B. AU - Sawaya, R. AU - Kondo, S. AU - Kondo, Y. PY - 2007 DA - 2007// TI - Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy JO - Int J Oncol VL - 31 ID - Fujiwara2007 ER - TY - JOUR AU - Yap, T. A. AU - Yan, L. AU - Patnaik, A. AU - Fearen, I. AU - Olmos, D. AU - Papadopoulos, K. PY - 2011 DA - 2011// TI - First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.5263 DO - 10.1200/JCO.2011.35.5263 ID - Yap2011 ER - TY - JOUR AU - Li, H. -. F. AU - Kim, J. -. S. AU - Waldman, T. PY - 2009 DA - 2009// TI - Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells JO - Radiat Oncol VL - 4 UR - https://doi.org/10.1186/1748-717X-4-43 DO - 10.1186/1748-717X-4-43 ID - Li2009 ER - TY - JOUR AU - Chautard, E. AU - Loubeau, G. AU - Tchirkov, A. AU - Chassagne, J. AU - Vermot-Desroches, C. AU - Morel, L. PY - 2010 DA - 2010// TI - Akt signaling pathway: a target for radiosensitizing human malignant glioma JO - Neuro-oncology VL - 12 ID - Chautard2010 ER - TY - JOUR AU - Holler, M. AU - Grottke, A. AU - Mueck, K. AU - Manes, J. AU - Jücker, M. AU - Rodemann, H. P. PY - 2016 DA - 2016// TI - Dual targeting of Akt and mTORC1 impairs repair of DNA double-Strand breaks and increases radiation sensitivity of human tumor cells JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0154745 DO - 10.1371/journal.pone.0154745 ID - Holler2016 ER - TY - JOUR AU - Kroemer, G. AU - Galluzzi, L. AU - Vandenabeele, P. AU - Abrams, J. AU - Alnemri, E. S. AU - Baehrecke, E. H. PY - 2009 DA - 2009// TI - Nomenclature committee on cell death 2009. Classification of cell death: recommendations of the nomenclature committee on cell death 2009 JO - Cell Death Differ VL - 16 UR - https://doi.org/10.1038/cdd.2008.150 DO - 10.1038/cdd.2008.150 ID - Kroemer2009 ER - TY - JOUR AU - Djuzenova, C. S. AU - Fiedler, V. AU - Katzer, A. AU - Michel, K. AU - Deckert, S. AU - Zimmermann, H. PY - 2016 DA - 2016// TI - Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: the role of drug-irradiation schedule JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.9501 DO - 10.18632/oncotarget.9501 ID - Djuzenova2016 ER - TY - JOUR AU - Memmel, S. AU - Sisario, D. AU - Zöller, C. AU - Fiedler, V. AU - Katzer, A. AU - Heiden, R. PY - 2017 DA - 2017// TI - Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.16847 DO - 10.18632/oncotarget.16847 ID - Memmel2017 ER - TY - JOUR AU - Unkel, S. AU - Belka, C. AU - Lauber, K. PY - 2016 DA - 2016// TI - On the analysis of clonogenic survival data: statistical alternatives to the linear-quadratic model JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0584-z DO - 10.1186/s13014-016-0584-z ID - Unkel2016 ER - TY - JOUR AU - Maser, R. S. AU - Monsen, K. J. AU - Nelms, B. E. AU - Petrini, J. H. PY - 1997 DA - 1997// TI - hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks JO - Mol Cell Biol VL - 17 UR - https://doi.org/10.1128/MCB.17.10.6087 DO - 10.1128/MCB.17.10.6087 ID - Maser1997 ER - TY - JOUR AU - Mirzoeva, O. K. AU - Petrini, J. H. PY - 2001 DA - 2001// TI - DNA damage-dependent nuclear dynamics of the Mre11 complex JO - Mol Cell Biol VL - 21 UR - https://doi.org/10.1128/MCB.21.1.281-288.2001 DO - 10.1128/MCB.21.1.281-288.2001 ID - Mirzoeva2001 ER - TY - JOUR AU - Frey, B. AU - Stache, C. AU - Rubner, Y. AU - Werthmöller, N. AU - Schulz, K. AU - Sieber, R. PY - 2012 DA - 2012// TI - Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential JO - J Immunotoxicol VL - 9 UR - https://doi.org/10.3109/1547691X.2012.693547 DO - 10.3109/1547691X.2012.693547 ID - Frey2012 ER - TY - JOUR AU - Sukhorukov, V. L. AU - Djuzenova, C. S. AU - Arnold, W. M. AU - Zimmermann, U. PY - 1994 DA - 1994// TI - DNA, protein, and plasma-membrane incorporation by arrested mammalian cells JO - J Membr Biol VL - 142 UR - https://doi.org/10.1007/BF00233385 DO - 10.1007/BF00233385 ID - Sukhorukov1994 ER - TY - JOUR AU - Karagounis, I. V. AU - Kalamida, D. AU - Mitrakas, A. AU - Pouliliou, S. AU - Liousia, M. V. AU - Giatromanolaki, A. PY - 2016 DA - 2016// TI - Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy JO - Br J Cancer VL - 115 UR - https://doi.org/10.1038/bjc.2016.202 DO - 10.1038/bjc.2016.202 ID - Karagounis2016 ER - TY - JOUR AU - Saleh, T. AU - Cuttino, L. AU - Gewirtz, D. A. PY - 2016 DA - 2016// TI - Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer JO - Biochim Biophys Acta VL - 1860 UR - https://doi.org/10.1016/j.bbagen.2016.06.012 DO - 10.1016/j.bbagen.2016.06.012 ID - Saleh2016 ER - TY - JOUR AU - Fan, Q. -. W. AU - Cheng, C. AU - Hackett, C. AU - Feldman, M. AU - Houseman, B. T. AU - Nicolaides, T. PY - 2010 DA - 2010// TI - Akt and autophagy cooperate to promote survival of drug-resistant glioma JO - Sci Signal VL - 3 UR - https://doi.org/10.1126/scisignal.2001017 DO - 10.1126/scisignal.2001017 ID - Fan2010 ER - TY - JOUR AU - Di, J. AU - Tang, J. AU - Qian, H. AU - Franklin, D. A. AU - Deisenroth, C. AU - Itahana, Y. PY - 2017 DA - 2017// TI - p53 upregulates PLCε-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B JO - Oncotarget VL - 8 ID - Di2017 ER - TY - JOUR AU - Fingar, D. C. AU - Richardson, C. J. AU - Tee, A. R. AU - Cheatham, L. AU - Tsou, C. AU - Blenis, J. PY - 2004 DA - 2004// TI - mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E JO - Mol Cell Biol VL - 24 UR - https://doi.org/10.1128/MCB.24.1.200-216.2004 DO - 10.1128/MCB.24.1.200-216.2004 ID - Fingar2004 ER - TY - JOUR AU - Foster, D. A. AU - Yellen, P. AU - Xu, L. AU - Saqcena, M. PY - 2010 DA - 2010// TI - Regulation of G1 cell cycle progression: distinguishing the restriction point from a nutrient-sensing cell growth checkpoint(s) JO - Genes Cancer VL - 1 UR - https://doi.org/10.1177/1947601910392989 DO - 10.1177/1947601910392989 ID - Foster2010 ER - TY - JOUR AU - McCubrey, J. A. AU - Steelman, L. S. AU - Chappell, W. H. AU - Abrams, S. L. AU - Wong, E. W. T. AU - Chang, F. PY - 2007 DA - 2007// TI - Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance JO - Biochim Biophys Acta VL - 1773 UR - https://doi.org/10.1016/j.bbamcr.2006.10.001 DO - 10.1016/j.bbamcr.2006.10.001 ID - McCubrey2007 ER - TY - JOUR AU - Dhillon, A. S. AU - Hagan, S. AU - Rath, O. AU - Kolch, W. PY - 2007 DA - 2007// TI - MAP kinase signalling pathways in cancer JO - Oncogene. VL - 26 UR - https://doi.org/10.1038/sj.onc.1210421 DO - 10.1038/sj.onc.1210421 ID - Dhillon2007 ER - TY - JOUR AU - Steelman, L. S. AU - Chappell, W. H. AU - Abrams, S. L. AU - Kempf, R. C. AU - Long, J. AU - Laidler, P. PY - 2011 DA - 2011// TI - Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging JO - Aging (Albany NY) VL - 3 UR - https://doi.org/10.18632/aging.100296 DO - 10.18632/aging.100296 ID - Steelman2011 ER - TY - JOUR AU - Huang, C. AU - Jacobson, K. AU - Schaller, M. D. PY - 2004 DA - 2004// TI - MAP kinases and cell migration JO - J Cell Sci VL - 117 UR - https://doi.org/10.1242/jcs.01481 DO - 10.1242/jcs.01481 ID - Huang2004 ER - TY - JOUR AU - Sato, T. AU - Nakashima, A. AU - Guo, L. AU - Tamanoi, F. PY - 2009 DA - 2009// TI - Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M809207200 DO - 10.1074/jbc.M809207200 ID - Sato2009 ER - TY - JOUR AU - Branzei, D. AU - Foiani, M. PY - 2008 DA - 2008// TI - Regulation of DNA repair throughout the cell cycle JO - Nat Rev Mol Cell Biol VL - 9 UR - https://doi.org/10.1038/nrm2351 DO - 10.1038/nrm2351 ID - Branzei2008 ER - TY - JOUR AU - Djuzenova, C. S. AU - Fiedler, V. AU - Memmel, S. AU - Katzer, A. AU - Hartmann, S. AU - Krohne, G. AU - Zimmermann, H. AU - Scholz, C. J. AU - Polat, B. AU - Flentje, M. AU - Sukhorukov, V. L. PY - 2015 DA - 2015// TI - Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status JO - Exp Cell Res VL - 330 UR - https://doi.org/10.1016/j.yexcr.2014.08.013 DO - 10.1016/j.yexcr.2014.08.013 ID - Djuzenova2015 ER - TY - JOUR AU - Memmel, S. AU - Sukhorukov, V. L. AU - Höring, M. AU - Westerling, K. AU - Fiedler, V. AU - Katzer, A. PY - 2014 DA - 2014// TI - Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0087052 DO - 10.1371/journal.pone.0087052 ID - Memmel2014 ER - TY - JOUR AU - Saxton, R. A. AU - Sabatini, D. M. PY - 2017 DA - 2017// TI - mTOR signaling in growth, metabolism, and disease JO - Cell VL - 168 UR - https://doi.org/10.1016/j.cell.2017.02.004 DO - 10.1016/j.cell.2017.02.004 ID - Saxton2017 ER - TY - JOUR AU - Tanaka, M. AU - Kikuchi, T. AU - Uno, H. AU - Okita, K. AU - Kitanishi-Yumura, T. AU - Yumura, S. PY - 2017 DA - 2017// TI - Turnover and flow of the cell membrane for cell migration JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-13438-5 DO - 10.1038/s41598-017-13438-5 ID - Tanaka2017 ER - TY - JOUR AU - Manning, B. D. AU - Cantley, L. C. PY - 2007 DA - 2007// TI - AKT/PKB signaling: navigating downstream JO - Cell. VL - 129 UR - https://doi.org/10.1016/j.cell.2007.06.009 DO - 10.1016/j.cell.2007.06.009 ID - Manning2007 ER - TY - JOUR AU - Irie, H. Y. AU - Pearline, R. V. AU - Grueneberg, D. AU - Hsia, M. AU - Ravichandran, P. AU - Kothari, N. AU - Natesan, S. AU - Brugge, J. S. PY - 2005 DA - 2005// TI - Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition JO - J Cell Biol VL - 171 UR - https://doi.org/10.1083/jcb.200505087 DO - 10.1083/jcb.200505087 ID - Irie2005 ER - TY - JOUR AU - Meng, Q. AU - Xia, C. AU - Fang, J. AU - Rojanasakul, Y. AU - Jiang, B. H. PY - 2006 DA - 2006// TI - Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway JO - Cell Signal VL - 18 UR - https://doi.org/10.1016/j.cellsig.2006.05.019 DO - 10.1016/j.cellsig.2006.05.019 ID - Meng2006 ER - TY - JOUR AU - Mehta, M. AU - Khan, A. AU - Danish, S. AU - Haffty, B. G. AU - Sabaawy, H. E. PY - 2015 DA - 2015// TI - Radiosensitization of primary human glioblastoma stem-like cells with low-dose AKT inhibition JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0708 DO - 10.1158/1535-7163.MCT-14-0708 ID - Mehta2015 ER - TY - JOUR AU - Fortier, A. M. AU - Asselin, E. AU - Cadrin, M. PY - 2011 DA - 2011// TI - Functional specificity of Akt isoforms in cancer progression JO - Biomol Concepts VL - 2 UR - https://doi.org/10.1515/bmc.2011.003 DO - 10.1515/bmc.2011.003 ID - Fortier2011 ER - TY - JOUR AU - Memmott, R. M. AU - Dennis, P. A. PY - 2009 DA - 2009// TI - Akt-dependent and -independent mechanisms of mTOR regulation in cancer JO - Cell Signal VL - 21 UR - https://doi.org/10.1016/j.cellsig.2009.01.004 DO - 10.1016/j.cellsig.2009.01.004 ID - Memmott2009 ER - TY - JOUR AU - Chappell, W. H. AU - Steelman, L. S. AU - Long, J. M. AU - Kempf, R. C. AU - Abrams, S. L. AU - Franklin, R. A. PY - 2011 DA - 2011// TI - Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health JO - Oncotarget VL - 2 UR - https://doi.org/10.18632/oncotarget.240 DO - 10.18632/oncotarget.240 ID - Chappell2011 ER - TY - JOUR AU - Aksamitiene, E. AU - Kholodenko, B. N. AU - Kolch, W. AU - Hoek, J. B. AU - Kiyatkin, A. PY - 2010 DA - 2010// TI - PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells JO - Cell Signal VL - 22 UR - https://doi.org/10.1016/j.cellsig.2010.05.006 DO - 10.1016/j.cellsig.2010.05.006 ID - Aksamitiene2010 ER -